Dramatically Worse Myeloma Outcomes in Real World vs. Trials - report from ASH2023

from Medical Digest & Congress Report · host Medical Congress News

Dr. Alissa Visram on the presented the data during 65th American Society of Hematology Annual Meeting. Patients with multiple myeloma who were treated in the real world had 44% worse progression-free survival and 75% worse overall survival than patients treated on clinical trials, according to a pooled analysis of efficacy versus effectiveness for seven MM regimens. Video: https://medicaldigest.org/scientific-contents/interview:dramatically-worse-myeloma-outcomes-real-world-vs-trials

Episode metadata supplied by the publisher feed · Published Dec 20, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

Dramatically Worse Myeloma Outcomes in Real World vs. Trials - report from ASH2023

0:00 6:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 6 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on December 20, 2023.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!